IMMPRAIM
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97929125
- Registration number
- 8026899
- Mark type
- Stylized text
- Filed
- 10 May 2023
- Published for opposition
- 05 Nov 2024
- Registered
- 18 Nov 2025
- Attorney of record
- Andrew D. Price & Paula E. Hopkins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
Owner
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
- Immunocore Limited, Abingdon, Oxfordshire, GB
Prosecution history
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 17 Dec 2024 — NOTICE OF ALLOWANCE CANCELLED
- 27 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Dec 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Sept 2024 — ASSIGNED TO LIE
- 22 May 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED